Stocks and InvestingStocks and Investing
Thu, March 18, 2021
Wed, March 17, 2021
Tue, March 16, 2021
Mon, March 15, 2021
Sun, March 14, 2021
Fri, March 12, 2021
Thu, March 11, 2021

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $130 on, Mar 11th, 2021


Published on 2024-10-27 15:54:47 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $126 to $130 on, Mar 11th, 2021.

Jayson has made no other calls on ABT in the last 4 months.



There are 7 other peers that have a rating on ABT. Out of the 7 peers that are also analyzing ABT, 1 agrees with Jayson's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $115 on, Saturday, February 6th, 2021


These are the ratings of the 6 analyists that currently disagree with Jayson


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $136 on, Thursday, January 28th, 2021
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $140 on, Thursday, January 28th, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $137 on, Thursday, January 28th, 2021
  • Marie Thibault of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $140 on, Thursday, January 28th, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Thursday, January 28th, 2021
  • Bob Hopkins of "B of A Securities" Maintained at Strong Buy with Increased Target to $145 on, Thursday, January 28th, 2021